Tags

Type your tag names separated by a space and hit enter

Mechanism of action of brexpiprazole: comparison with aripiprazole.
CNS Spectr. 2016 Feb; 21(1):1-6.CS

Abstract

Brexpiprazole is a new therapeutic agent that was recently approved for the treatment of schizophrenia and for the adjunctive treatment of major depressive disorder. Brexpiprazole has features that both overlap and contrast with a related molecule, aripiprazole, and these features are discussed here.

Authors

No affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

26899451

Citation

Stahl, Stephen M.. "Mechanism of Action of Brexpiprazole: Comparison With Aripiprazole." CNS Spectrums, vol. 21, no. 1, 2016, pp. 1-6.
Stahl SM. Mechanism of action of brexpiprazole: comparison with aripiprazole. CNS Spectr. 2016;21(1):1-6.
Stahl, S. M. (2016). Mechanism of action of brexpiprazole: comparison with aripiprazole. CNS Spectrums, 21(1), 1-6. https://doi.org/10.1017/S1092852915000954
Stahl SM. Mechanism of Action of Brexpiprazole: Comparison With Aripiprazole. CNS Spectr. 2016;21(1):1-6. PubMed PMID: 26899451.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Mechanism of action of brexpiprazole: comparison with aripiprazole. A1 - Stahl,Stephen M, PY - 2016/2/23/entrez PY - 2016/2/24/pubmed PY - 2016/7/20/medline SP - 1 EP - 6 JF - CNS spectrums JO - CNS Spectr VL - 21 IS - 1 N2 - Brexpiprazole is a new therapeutic agent that was recently approved for the treatment of schizophrenia and for the adjunctive treatment of major depressive disorder. Brexpiprazole has features that both overlap and contrast with a related molecule, aripiprazole, and these features are discussed here. SN - 1092-8529 UR - https://www.unboundmedicine.com/medline/citation/26899451/Mechanism_of_action_of_brexpiprazole:_comparison_with_aripiprazole_ DB - PRIME DP - Unbound Medicine ER -